How do you sequence the sales motion for a telehealth platform targeting provider groups vs. self-insured employers in 2027?

The go-to-market motion in one picture

The mistake most telehealth platforms make in 2027 is running one sales motion against two fundamentally different buyers and wondering why forecast accuracy sits at 40%. A provider group and a self-insured employer are not two segments of the same market. They are two separate businesses that happen to share a product. One buys a revenue tool. The other buys a benefit. One evaluates in 60–120 days against a P&L line it already owns. The other evaluates in 6–11 months against a plan-year calendar it cannot move.

Sequencing means deliberately deciding which motion you build first, which you starve, and what the first motion has to produce before the second one can even start. The wrong order — chasing employer logos first because the contract values look bigger — is the single most common way a telehealth company burns 18 months and a Series B.

Here is the shape of the correct sequence:

Notice the loop back into network density. The employer motion is not a downstream endpoint that consumes the provider motion — it feeds it. Every employer you close creates covered-life demand that makes you a more attractive partner to the next provider group, because you are bringing them patients rather than asking them for access. That flywheel only spins in one direction, and it will not start if you sequence employers first.

The practical implication for a 2027 build: your first two quarters of headcount should be almost entirely provider-facing. A single strategic partnerships hire can start the broker relationship-building in parallel — those relationships take 6–9 months to mature regardless of what your product does, so the calendar forces overlap. But quota-carrying employer reps hired before you have a proof pack are expensive people with nothing to sell.

There is a real trade-off here worth naming. Provider-first means slower ACV growth in year one. A provider group deal in this category typically lands somewhere in the $30K–$150K annual range depending on clinician count and whether you are charging per-provider, per-encounter, or a platform fee. A mid-market self-insured employer with 3,000–8,000 covered lives can be a $200K–$600K PEPM arrangement. Boards look at that gap and push for the employer motion. Resist it with the calendar argument: you physically cannot close a January 1 effective date without being in front of the broker by the prior spring, so the employer revenue you would book in the accelerated plan lands in the same fiscal quarter either way. You just skip the proof and lose the deal.

Who owns what across the revenue org

The org design failure in dual-motion telehealth is putting both motions under one VP of Sales with one comp plan. The two motions have different cycle lengths, different champion profiles, and different definitions of a qualified opportunity. A shared quota carrier will always work the provider deals — they close faster — and the employer pipeline will quietly rot.

Split the ownership explicitly.

Provider group motion. This is a clinical-operations sale dressed as a revenue sale. Your buyer is typically a practice administrator, a COO of a multi-site group, or a physician-owner in smaller practices. In groups above roughly 40 providers you will also encounter a CFO and often a revenue cycle director. The AE profile that wins here has healthcare revenue cycle fluency — they can talk about reimbursement parity, place-of-service coding, and what happens to the group's collections when 20% of visits shift to a virtual modality. Cycle: 60–120 days. Ratio: one AE can run 12–18 active opportunities. Support with a clinical solutions engineer who can answer scope-of-practice and documentation questions live, because a stalled clinical objection kills more deals here than pricing does.

Self-insured employer motion. This is a benefits sale, and it is fundamentally channel-mediated. You are not primarily selling to the employer. You are selling to the benefits consultant or broker who will put you on a shortlist, and then selling with them to the employer's HR and finance leadership. The AE profile is a benefits-industry person — someone who has worked at or alongside a consultancy, knows how a stop-loss carrier thinks, and understands that the actual economic buyer is often the CFO looking at a self-funded claims trend line. Cycle: 6–11 months, calendar-locked. Ratio: one AE can genuinely run 8–12 opportunities because each requires far more orchestration.

The channel function. Do not bury broker relationships inside an AE's job. Stand up a partnerships or channel role by month 6 whose entire job is consultant relationships — getting into the vendor evaluation databases those firms maintain, running education sessions for their practice leads, and being present in the spring when the shortlists get built. This role's metric is not revenue. It is qualified-opportunity creation from named consulting firms, and it should be measured on a 9-month lag.

Marketing splits too. Provider-side demand gen runs on specialty association channels, medical society events, and reimbursement-focused content. Employer-side runs on benefits conferences, HR publications, and consultant-facing collateral that is built to be forwarded rather than read. The same case study does not work in both directions — the provider version leads with per-encounter economics and clinician time, the employer version leads with claims trend and access time.

RevOps owns the seam. Two motions means two pipeline definitions, two stage sets, two forecast categories, and a shared account object that has to handle the case where an employer client's covered population overlaps a provider group's panel. Build that data model in month 1, not month 14. The specific thing that breaks: an employer closes, its members start booking with a provider group you already have under contract, and nobody can tell whether the resulting revenue is attributable to the employer contract or the provider contract. Decide the attribution rule before it matters, write it down, and make it a hard field in the CRM rather than a convention.

Finally, staff customer success asymmetrically. Provider accounts need onboarding-heavy support in the first 90 days — workflow integration, scheduling template changes, credentialing checks — then go relatively quiet. Employer accounts need light onboarding and then heavy, continuous engagement work, because a benefit nobody uses does not renew. Two different CS profiles, two different playbooks, two different renewal risk models.

Metrics, targets, and realistic ranges

Run separate scorecards. Blending them produces averages that describe neither motion.

Provider group motion. Expect a lead-to-opportunity conversion in the 8–15% range from outbound, higher from association-channel inbound. Opportunity-to-close for a competent team lands around 20–30% — healthcare practices are slow but they are not tire-kickers; if an administrator takes a second meeting there is usually a real problem being solved. Sales cycle 60–120 days, with the long tail driven by malpractice-carrier review and, in multi-site groups, a physician-partner vote that only happens monthly. Watch time-to-first-encounter as your true activation metric, not time-to-signature. A provider group that signs and does not run a virtual visit within 30 days has a materially elevated churn risk in the first renewal.

Self-insured employer motion. Conversion from qualified opportunity to close should be modeled at 15–25%, and the denominator matters enormously — an opportunity that entered without consultant sponsorship converts far below one that came in on a shortlist. Sales cycle 6–11 months. The metric people forget: percentage of pipeline that is calendar-viable. In August, an opportunity for a January 1 effective date is probably real. That same opportunity created in November is not a Q4 deal, it is a next-year deal, and forecasting it as current-period is how dual-motion companies miss badly. Add a required "target effective date" field and let the forecast logic use it.

Utilization is the metric that decides everything downstream. Employer contracts renew or die on engagement. Realistic first-year utilization for a well-implemented virtual care benefit generally sits in the single digits to low teens as a percentage of covered lives — and it depends heavily on whether the employer promotes it, whether there is a member cost-share, and whether you are the only access point or one of four. Set expectations at contract time rather than letting the consultant's optimistic model become the renewal benchmark. Nothing damages a second-year conversation more than a client comparing actual utilization to a number you never actually committed to.

Network adequacy metrics gate the employer motion. Before you sell an employer, you need a defensible answer to "can my people get seen." Track median time-to-appointment by specialty and by metro, and percentage of covered population within your coverage footprint. If you cannot answer those two questions with real data from live provider accounts, you are not ready to run the employer motion regardless of what your pipeline says.

Blended CAC will mislead you. Provider CAC payback might sit at 12–18 months on a $60K ACV. Employer CAC payback on a $350K contract with a 9-month cycle and channel compensation layered in can look worse in the first year and dramatically better by year three, because employer contracts renew at higher rates once utilization is established. Model them separately, and model employer LTV on a three-year horizon or you will underinvest in exactly the motion that compounds.

One practical forecasting note: because the employer motion is calendar-locked, your annual revenue shape is lumpy in a way SaaS boards are not used to. A large share of new employer ARR books in a narrow window. Build the plan around that rather than spreading employer quota evenly across four quarters, which produces a Q1 and Q2 that look like failure and a Q4 that looks like a miracle.

Where the motion breaks down

Sequencing employers first. Already covered, but it deserves the top slot because it is the most expensive error. Symptoms: long-dated pipeline that never converts, a partnerships hire who cannot get meetings because there is no proof, and a product roadmap being bent toward employer reporting features before the clinical workflow is stable.

The multi-state licensure and credentialing wall. An employer with a distributed workforce needs coverage in states where your provider network is thin. This is a supply problem masquerading as a sales problem, and no amount of AE effort fixes it. It shows up late — usually in the security-and-network-review stage, three months into an employer deal — and it kills deals that looked closed. Build a coverage map, publish it internally, and disqualify out-of-footprint employers early rather than letting reps burn a quarter on them.

Reimbursement policy drift on the provider side. Provider group economics depend on how virtual encounters are reimbursed, and that policy environment has shifted repeatedly. A provider deal justified on a specific reimbursement assumption becomes a churn risk if that assumption changes mid-contract. Two mitigations: build ROI models that hold up under a reduced-reimbursement scenario, and structure contracts so the group's value does not depend entirely on a single billing pathway. Groups that adopted for access, capacity, and after-hours coverage stay when the billing math tightens; groups that adopted purely as a billing arbitrage leave.

Confusing the broker for the customer. The consultant gets you on the list. They do not sign. Teams that over-index on channel relationships build a pipeline of warm introductions with no economic buyer engaged, then discover in month seven that the CFO has never heard of them. Rule: no opportunity advances past mid-stage without direct finance-side contact. Make it a stage-gate field, not a coaching suggestion.

Pilots that never end. Employers love pilots. Pilots produce no revenue, consume implementation capacity, and often generate weak utilization data because they run against a small unpromoted subpopulation. If you run pilots, they need a defined end date, a pre-agreed success threshold, and a signed conversion price. An open-ended pilot is a free trial with a project plan attached.

Channel conflict between the two motions. Your employer client's members book with a provider group that is also your customer. Who owns the relationship, who gets the utilization credit, and what happens when the employer wants a different provider group in that market? This is a real operational conflict and it is not theoretical. Write the rules of engagement before the first overlap, because writing them after means renegotiating with a customer.

Underestimating the security and procurement review. A self-insured employer's evaluation includes a security review, a business associate agreement, and often a review by the stop-loss carrier or TPA. That process adds 6–10 weeks and it does not compress. Have the documentation package assembled before your first employer opportunity reaches proposal stage — SOC 2 report, HIPAA documentation, subprocessor list, penetration test summary, and a completed standard security questionnaire. Reps should never be assembling this in real time.

Comp plan mismatch. If employer AEs are on a standard annual quota with quarterly accelerators, the calendar lock destroys them for three quarters and overpays them in one. Use annual quota with a longer measurement period, a meaningful draw for the ramp, and pipeline-creation-based components in the off-cycle quarters. Otherwise you lose the reps who were doing the right work at the wrong time of year.

How to sequence the build

The build sequence is not just a sales-hiring plan. Product, network operations, compliance, and marketing all have gating dependencies, and the common failure is running them in parallel at equal intensity instead of in dependency order.

A few notes on that sequence.

Narrow the provider ICP harder than feels comfortable. Two or three specialties in two or three metros. Density beats breadth in the first year because employer buyers ask geographic questions, and "we have 200 providers scattered across 31 states" is a worse answer than "we have full coverage in these four markets." Breadth is a year-two problem.

Founder-led selling through the first 8–10 provider accounts. Not because founders sell better, but because the ICP and the objection set are still moving. Hiring AEs before the playbook stabilizes produces reps who learn the wrong pitch and a manager who cannot tell whether misses are talent or product.

Compliance work starts a full year before the employer revenue. SOC 2 Type II requires an observation window. If your first employer deal reaches security review in month 14 and you started the audit in month 12, you have a report that does not exist yet and a deal that slips a plan year — twelve months, not one quarter.

Consultant relationships run in parallel from month 6. This is the one thread that cannot wait for the provider motion to finish, because relationship maturity is time-gated, not effort-gated. But the partnerships lead should be building credibility and education presence, not pitching a proof pack that does not exist yet.

The adjacent motions worth planning for. Once both motions run, three neighboring paths open up. Health plans and TPAs become a channel — they aggregate many employers, and one plan relationship can substitute for dozens of direct employer deals, though at lower economics and with a longer procurement cycle. PEOs and association health plans give access to small-employer populations that would never justify a direct sale. And a partner-led motion through EHR vendors and practice management platforms can accelerate the provider side considerably. None of these should be started in year one, but the data model and contracting templates you build should not preclude them. A pricing structure that only works for direct-to-employer PEPM will need to be rebuilt when the first TPA conversation happens.

Instrument the handoff points. The two moments where revenue leaks are provider-signature-to-first-encounter and employer-signature-to-member-activation. Both are implementation problems that read as sales problems six months later. Put a named owner and a hard SLA on each before you scale either motion.

Related questions

Should we ever sell to employers first?

Only if you inherit a clinical network — through an acquisition, a health system partnership, or an existing provider business. Network density is the actual prerequisite. If you already have it, the sequencing argument dissolves and you can run the employer motion immediately.

How long before the employer motion produces revenue?

Realistically 12–20 months from the first partnerships hire to recognized revenue, because of the compliance window plus the plan-year calendar. Budget for that gap explicitly rather than discovering it in a board meeting.

Do we need separate pricing models for each buyer?

Yes. Providers generally buy per-provider or per-encounter against a revenue or capacity case. Employers buy PEPM or PMPM against a claims-trend case. Forcing one model onto both distorts the value story for at least one of them.

What is the smallest viable employer to target?

Below roughly 1,000 covered lives the economics rarely justify a direct sale — the cycle length is nearly identical to a 5,000-life employer. Reach smaller populations through PEOs, association plans, or broker-bundled offerings instead.

Can one AE run both motions?

Not sustainably. The faster provider cycle always wins the calendar, and employer pipeline decays quietly. If headcount forces it, at least separate the quotas and measure employer pipeline creation independently.

FAQ

Why does the plan-year calendar dominate the employer motion so completely?

Most self-insured employer benefit changes take effect January 1, and the decisions are made during a shortlisting and evaluation window that runs roughly spring through early fall, with open enrollment communication in the fall. A vendor that is not in the evaluation by mid-summer is generally not in that plan year at all. This makes the employer sales cycle calendar-locked rather than effort-locked — you cannot compress it with more activity, only with earlier entry.

What proof do employers actually want from the provider network?

Three things, in order: can my people get seen quickly, in the places they live; is the clinical quality defensible; and does this reduce or redirect spend in a way my claims data will show. Median time-to-appointment by specialty and geography is the single most persuasive artifact, and it can only come from live provider accounts. That is why the provider motion has to run first.

How should we compensate the partnerships or channel role?

Not on closed revenue in year one — the lag will make the role look like a failure and the person will quit before the pipeline matures. Use a mix of relationship milestones (evaluation-database inclusion, named-firm education sessions delivered, shortlist appearances) and a lagged revenue component measured on a 9–12 month trailing basis. Revisit annually once the motion is established.

Is the same product actually serving both buyers, or are we building twice?

The clinical core is shared. What diverges is reporting, integration, and administration. Employers need eligibility file handling, population-level reporting, member communications, and often integration with a benefits navigation platform. Providers need scheduling and documentation integration into their existing systems. Budget for roughly 20–30% of engineering capacity going to buyer-specific surface area once both motions are live, and sequence the employer-specific work to land before the first employer implementation, not during it.

What should we disqualify on early in the employer motion?

Geographic mismatch against your coverage map, no consultant sponsorship combined with no direct finance contact, a target effective date less than six months out, and populations under roughly 1,000 lives unless they come bundled. Each of those predicts a stalled cycle, and disqualifying them early is worth more than any late-stage closing technique.

How do we keep the provider motion from stalling once employer deals start closing?

Protect the provider quota and headcount explicitly. The gravitational pull toward larger employer contracts is strong, and provider growth is what makes employer growth possible. Set network density targets by metro as a company-level goal, not a sales-team goal, so the provider motion is measured against coverage rather than only against bookings.

Sources

• https://www.cms.gov/medicare/coverage/telehealth
• https://www.kff.org/health-costs/report/employer-health-benefits-annual-survey/
• https://www.dol.gov/agencies/ebsa/about-ebsa/our-activities/resource-center/publications/understanding-your-fiduciary-responsibilities-under-a-group-health-plan
• https://www.hhs.gov/hipaa/for-professionals/special-topics/telehealth/index.html
• https://www.ncqa.org/
• https://www.medicaid.gov/medicaid/benefits/telehealth/index.html
• https://www.shrm.org/topics-tools/topics/benefits-compensation
• https://www.ftc.gov/business-guidance/resources/health-breach-notification-rule
• https://www.healthit.gov/topic/health-it-and-health-information-exchange-basics/telehealth

Related on PULSE

• [How do you build an outbound motion for a legaltech platform in 2027?](/knowledge/gp560)
• [How do you structure SDR compensation to align with a product-led sales motion in 2027?](/knowledge/gp538)
• [What is the ideal sequence of sales motions for a PLG company moving upmarket in 2027?](/knowledge/gp545)
• [What is the best outreach sequence length for SDRs targeting VP-level buyers in 2027?](/knowledge/gp549)
• [How do you build a compliance training platform go-to-market motion in 2027?](/knowledge/gp0069)
• [What is the best go-to-market motion for selling a compliance platform to mid-market banks in 2027?](/knowledge/gp541)